| Product Code: ETC10110738 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Zambia Antimicrobial Resistance Market Overview |
3.1 Zambia Country Macro Economic Indicators |
3.2 Zambia Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Zambia Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Zambia Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Zambia Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Zambia Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Zambia Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Zambia Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Zambia Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Zambia |
4.2.2 Rise in the geriatric population leading to higher antimicrobial consumption |
4.2.3 Growing awareness about antimicrobial resistance among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Limited access to quality healthcare facilities in remote areas of Zambia |
4.3.2 Lack of stringent regulations and guidelines for antimicrobial use |
4.3.3 High cost of antimicrobial drugs leading to affordability issues for patients |
5 Zambia Antimicrobial Resistance Market Trends |
6 Zambia Antimicrobial Resistance Market, By Types |
6.1 Zambia Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Zambia Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Zambia Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Zambia Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Zambia Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Zambia Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Zambia Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Zambia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Zambia Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Zambia Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Zambia Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Zambia Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Zambia Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Zambia Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Zambia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Zambia Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Zambia Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Zambia Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Zambia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Zambia Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Zambia Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Zambia Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Zambia Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Zambia Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Zambia Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Zambia Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Zambia Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Zambia Antimicrobial Resistance Market Export to Major Countries |
7.2 Zambia Antimicrobial Resistance Market Imports from Major Countries |
8 Zambia Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage increase in public health campaigns raising awareness about antimicrobial resistance |
8.2 Number of healthcare facilities implementing antimicrobial stewardship programs |
8.3 Rate of adoption of alternative therapies to reduce antimicrobial usage |
9 Zambia Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Zambia Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Zambia Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Zambia Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Zambia Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Zambia Antimicrobial Resistance Market - Competitive Landscape |
10.1 Zambia Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Zambia Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here